Cargando…

Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome

BACKGROUND: Glomerular damage is a common clinical indicator of nephrotic syndrome. High-dose hormone treatment often leads to hormone resistance in patients. How to avoid resistance and improve the efficiency of hormone therapy draws much attention to clinicians. METHODS: Adriamycin (ADR) was used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Juan, Xue, Guozhong, Zhang, Yunxia, Wang, Xinbin, Dai, Enlai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881371/ https://www.ncbi.nlm.nih.gov/pubmed/36707848 http://dx.doi.org/10.1186/s40001-022-00973-9

Ejemplares similares

The effectiveness of cyclosporine A for patients with steroid-resistant nephrotic syndrome: A protocol for systematic review and meta-analysis
por: Lv, Juan, et al.
Publicado: (2021)

Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: A protocol of systematic review and meta-analysis of randomized controlled trials
por: Xue, Guozhong, et al.
Publicado: (2021)

Engineering antioxidant ceria-zirconia nanomedicines for alleviating podocyte injury in rats with adriamycin-induced nephrotic syndrome
por: Liu, Lili, et al.
Publicado: (2023)

Effects of Dietary Protein and Fat Contents on Renal Function and Inflammatory Cytokines in Rats with Adriamycin-Induced Nephrotic Syndrome
por: Kim, Su Yeon, et al.
Publicado: (2011)

CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
por: Gao, Jian, et al.
Publicado: (2018)

tRNA-Derived Fragments in Podocytes with Adriamycin-Induced Injury Reveal the Potential Mechanism of Idiopathic Nephrotic Syndrome
por: Li, Shanwen, et al.
Publicado: (2020)

Mild electrical stimulation with heat shock attenuates renal pathology in adriamycin-induced nephrotic syndrome mouse model
por: Teramoto, Keisuke, et al.
Publicado: (2020)

Comparative Study of Fucoidan from Saccharina japonica and Its Depolymerized Fragment on Adriamycin-Induced Nephrotic Syndrome in Rats
por: Tan, Jiaojiao, et al.
Publicado: (2020)

Protection Effect of Zhen-Wu-Tang on Adriamycin-Induced Nephrotic Syndrome via Inhibiting Oxidative Lesions and Inflammation Damage
por: Liang, Chun-ling, et al.
Publicado: (2014)

Differences in Multicomponent Pharmacokinetics, Tissue Distribution, and Excretion of Tripterygium Glycosides Tablets in Normal and Adriamycin–Induced Nephrotic Syndrome Rat Models and Correlations With Efficacy and Hepatotoxicity
por: Wu, Wei, et al.
Publicado: (2022)

The protective effect of icariin and phosphorylated icariin against LPS-induced intestinal goblet cell dysfunction
por: Xiong, Wen, et al.
Publicado: (2019)

The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone.
por: Wardley, A. M., et al.
Publicado: (1998)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
por: Hulkko, Jenny, et al.
Publicado: (2014)

Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis
por: Hu, Qiong-Dan, et al.
Publicado: (2023)

Ruxolitinib Synergizes With Dexamethasone for the Treatment of T-cell Acute Lymphoblastic Leukemia
por: Verbeke, Delphine, et al.
Publicado: (2019)

Therapeutic Nanodiamonds Containing Icariin Ameliorate the Progression of Osteoarthritis in Rats
por: Yu, Ying, et al.
Publicado: (2023)

Icariin ameliorates dexamethasone-induced bone deterioration in an experimental mouse model via activation of microRNA-186 inhibition of cathepsin K
por: Ma, Yongsheng, et al.
Publicado: (2018)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity
por: Liang, Zhenxing, et al.
Publicado: (2021)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Nephrotic syndrome-induced thromboembolism in adults
por: Al-Azzawi, Hasan F., et al.
Publicado: (2016)

The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
por: Follin-Arbelet, Virginie, et al.
Publicado: (2015)

Effect of adriamycin on CFUGM at plasma concentrations found following therapeutic infusions.
por: Bailey-Wood, R., et al.
Publicado: (1984)

Protective effect of melatonin against Adriamycin-induced cardiotoxicity
por: ZHANG, YAN, et al.
Publicado: (2013)

Bone mesenchymal stem cell-derived exosomes involved co-delivery and synergism effect with icariin via mussel-inspired multifunctional hydrogel for cartilage protection
por: Zeng, Jia, et al.
Publicado: (2023)

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014)

Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway
por: Liu, Xiu‐Juan, et al.
Publicado: (2021)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications
por: Doucet, Alain, et al.
Publicado: (2007)

Clinical and laboratory findings and therapeutic responses in children with nephrotic syndrome
por: Safaei, A. A. S. L., et al.
Publicado: (2010)

Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?
por: Saleem, Moin A., et al.
Publicado: (2019)

Dynamic Metabolic Response to Adriamycin-Induced Senescence in Breast Cancer Cells
por: You, Rong, et al.
Publicado: (2018)

Astragalus Polysaccharide Promotes Adriamycin-Induced Apoptosis in Gastric Cancer Cells
por: Song, Jie, et al.
Publicado: (2020)

Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death
por: Argueta, Christian, et al.
Publicado: (2018)

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma
por: Chim, C. S., et al.
Publicado: (2010)

The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome
por: Hussain, Neesha, et al.
Publicado: (2013)

Sunitinib induced nephrotic syndrome and thrombotic microangiopathy
por: Jha, P. K., et al.
Publicado: (2013)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
por: Qin, Lu-Yun, et al.
Publicado: (2022)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
por: Sun, Wenxia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_34g4b33ot1hn8r3rfhcss7i5d2